| Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test | Frank Vinluan | 07/15/20 | Boston |
| Early COVID-19 Vaccine Data Sets Up Moderna for Next Stages of Testing | Frank Vinluan | 05/18/20 | Boston |
| Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever | Ben Fidler | 12/06/18 | Boston |
| Going Against the Grain: Meet the Xconomy Contrarian Award Finalists | Ben Fidler | 08/01/18 | Boston |
| The 2018 Xconomy Awards Finalists Are… | Corie Lok | 06/28/18 | Boston |
| Moderna’s Billions: Will Building Big Before an IPO Pay Off? | Ben Fidler | 05/09/18 | Boston |
| Moderna, Still Private, Scoops Up Yet Another $500M | Ben Fidler | 02/01/18 | Boston |
| Moderna Ends “Venture” Experiment, Dissolves Four Startups | Ben Fidler | 09/14/17 | Boston |
| Filing: Moderna Blowing Past Record $450M Round With New $600M Raise | Ben Fidler | 08/29/16 | Boston |
| With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs | Frank Vinluan | 07/06/16 | Boston |
| Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact | Ben Fidler | 06/29/16 | Boston |
| Bought By Utah Rival Tute, Former Genomics High Flyer Knome Bows Out | Alex Lash | 11/02/15 | Boston |
| East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More | Ben Fidler | 10/23/15 | Boston |
| With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz | Ben Fidler | 10/22/15 | Boston |
| CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard | Ben Fidler | 09/10/15 | Boston |
| How Will Boston’s Innovation Cluster Look in 2035? Three More Predictions | Gregory T. Huang | 06/04/15 | Boston |
| Boston’s Innovation Future Hinges on People, Startups, Relationships | Gregory T. Huang | 05/21/15 | Boston |
| East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More | Ben Fidler | 05/15/15 | Boston |
| Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases | Ben Fidler | 05/12/15 | Boston |
| Announcing Boston 2035: Innovating the Future Starts Now | Gregory T. Huang | 04/15/15 | Boston |
| Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within | Ben Fidler | 01/21/15 | Boston |
| Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA | Ben Fidler | 01/08/15 | Boston |
| With Massive Venture Round, Moderna Has $450M Reasons to Stay Private | Ben Fidler | 01/05/15 | Boston |
| East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More | Ben Fidler | 06/20/14 | Boston |
| Moderna, Changing Its Identity, Plots Army of mRNA Spinouts | Ben Fidler | 06/12/14 | Boston |
| East Coast Biotech Roundup: JP Morgan Edition | Ben Fidler | 01/17/14 | Boston |
| Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido | Luke Timmerman | 01/14/14 | Boston |
| Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs | Luke Timmerman | 11/20/13 | Boston |
| Boston’s Life Science Disruptors: The Photos | Ben Fidler | 10/07/13 | Boston |
| 9 Takeaways from Boston’s Life Science Disruptors | Ben Fidler | 10/04/13 | Boston |
